Login / Signup

The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection.

Vonetta L EdwardsSteven B SmithElias J McCombJeanne TamarelleBing MaMichael S HumphrysPawel GajerKathleen GwilliamAlison M SchaeferSamuel K LaiMishka TerplanKatrina S MarkRebecca M BrotmanLarry J ForneyPatrik M BavoilJacques Ravel
Published in: mBio (2019)
The mechanism(s) by which Lactobacillus-dominated cervicovaginal microbiota provide a barrier to Chlamydia trachomatis infection remain(s) unknown. Here we evaluate the impact of different Lactobacillus spp. identified via culture-independent metataxonomic analysis of C. trachomatis-infected women on C. trachomatis infection in a three-dimensional (3D) cervical epithelium model. Lactobacillus spp. that specifically produce d(-) lactic acid were associated with long-term protection against C. trachomatis infection, consistent with reduced protection associated with Lactobacillus iners, which does not produce this isoform, and with decreased epithelial cell proliferation, consistent with the observed prolonged protective effect. Transcriptomic analysis revealed that epigenetic modifications involving histone deacetylase-controlled pathways are integral to the cross talk between host and microbiota. These results highlight a fundamental mechanism whereby the cervicovaginal microbiota modulates host functions to protect against C. trachomatis infection.IMPORTANCE The vaginal microbiota is believed to protect women against Chlamydia trachomatis, the etiologic agent of the most prevalent sexually transmitted infection (STI) in developed countries. The mechanism underlying this protection has remained elusive. Here, we reveal the comprehensive strategy by which the cervicovaginal microbiota modulates host functions to protect against chlamydial infection, thereby providing a novel conceptual mechanistic understanding. Major implications of this work are that (i) the impact of the vaginal microbiota on the epithelium should be considered in future studies of chlamydial infection and other STIs and (ii) a fundamental understanding of the cervicovaginal microbiota's role in protection against STIs may enable the development of novel microbiome-based therapeutic strategies to protect women from infection and improve vaginal and cervical health.
Keyphrases
  • cell proliferation
  • lactic acid
  • polycystic ovary syndrome
  • type diabetes
  • skeletal muscle
  • histone deacetylase
  • dna methylation
  • men who have sex with men
  • social media
  • pregnant women
  • breast cancer risk